Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Melanoma 4Endometrial Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neoplasm Metastasis 3Rectal Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1Multiple Myeloma 1Mouth Neoplasms 1Laryngeal Diseases 1Hodgkin Disease 1Hepatoblastoma 1Glioblastoma 1

Interventions

pembrolizumab 10Cisplatin 8Radiotherapy 6Magnetic Resonance Spectroscopy 6Carboplatin 6Specimen Handling 5Paclitaxel 5Brachytherapy 5Fluorodeoxyglucose F18 4dostarlimab 3atezolizumab 3Trastuzumab 3Radiation 3Platinum 3Nivolumab 3Human Papillomavirus DNA Tests 3Docetaxel 3Colposcopy 31,2-diaminocyclohexaneplatinum II citrate 3zimberelimab 2tislelizumab 2spartalizumab 2olaparib 2human papillomavirus vaccine, L1 type 16, 18 2durvalumab 2Vaccines 2Surveys and Questionnaires 2Standard of Care 2Robotic Surgical Procedures 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Uterine Cervical Neoplasms × dostarlimab × Clear all
NCT04068753 2026-02-10

STAR

University of Oklahoma

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06238635 2026-01-13

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Beth Israel Deaconess Medical Center

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03833479 2025-05-21

ATOMICC

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Active not recruiting
134 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡